Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith S Kaye

Showing results (71-80 of 421) with videos related to

Pageof 43
Sort By:
Infectious Diseases and Therapy|February 27, 2023
Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant EnterobacteralesKeith S Kaye, Thierry Naas, Jason M Pogue, et al.
Open Forum Infectious Diseases|June 13, 2024
Review of the In Vitro Microbiological Activity of Mecillinam Against Common Uropathogens in Uncomplicated Urinary Tract Infection: Focus on Resistant PathogensThomas P Lodise, Keith S Kaye, Anne Santerre Henriksen, et al.
Journal of the American Geriatrics Society|March 23, 2006
Risk factors for surgical site infections in older peopleKeith S Kaye, Richard Sloane, Daniel J Sexton, et al.
The Lancet. Microbe|May 2, 2026
Shift in pre-existing antibiotic heteroresistance explains change in antimicrobial susceptibility status from susceptible to resistant during patient treatmentBen Kittleson, Carter N Abbott, Keith S Kaye, et al.
Pharmacotherapy|September 5, 2014
Colistin: understanding and applying recent pharmacokinetic advancesJessica K Ortwine, Keith S Kaye, Jian Li, et al.
Infectious Disease Clinics of North America|August 17, 2004
Pathogens resistant to antimicrobial agents: epidemiology, molecular mechanisms, and clinical managementKeith S Kaye, John J Engemann, Henry S Fraimow, et al.
Archives of Internal Medicine|February 13, 2002
Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter speciesSara E Cosgrove, Keith S Kaye, George M Eliopoulous, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2025
Safety and Tolerability of Pivmecillinam During More Than Four Decades of Clinical Experience: A Systematic ReviewKeith S Kaye, Anne Santerre Henriksen, Morten Sommer, et al.
Infection Control and Hospital Epidemiology|December 11, 2023
Incidence and outcomes of hospital-associated respiratory virus infections by viral speciesJoshua G Petrie, Riley Moore, Adam S Lauring, et al.
Infection Control and Hospital Epidemiology|September 24, 2008
Complex surgical site infections and the devilish details of risk adjustment: important implications for public reportingDeverick J Anderson, Luke F Chen, Daniel J Sexton, et al.
Pageof 43

Showing results (71-80 of 421) with videos related to

Sort By:
Pageof 43
Infectious Diseases and Therapy|February 27, 2023
Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant EnterobacteralesKeith S Kaye, Thierry Naas, Jason M Pogue, et al.
Open Forum Infectious Diseases|June 13, 2024
Review of the In Vitro Microbiological Activity of Mecillinam Against Common Uropathogens in Uncomplicated Urinary Tract Infection: Focus on Resistant PathogensThomas P Lodise, Keith S Kaye, Anne Santerre Henriksen, et al.
Journal of the American Geriatrics Society|March 23, 2006
Risk factors for surgical site infections in older peopleKeith S Kaye, Richard Sloane, Daniel J Sexton, et al.
The Lancet. Microbe|May 2, 2026
Shift in pre-existing antibiotic heteroresistance explains change in antimicrobial susceptibility status from susceptible to resistant during patient treatmentBen Kittleson, Carter N Abbott, Keith S Kaye, et al.
Pharmacotherapy|September 5, 2014
Colistin: understanding and applying recent pharmacokinetic advancesJessica K Ortwine, Keith S Kaye, Jian Li, et al.
Infectious Disease Clinics of North America|August 17, 2004
Pathogens resistant to antimicrobial agents: epidemiology, molecular mechanisms, and clinical managementKeith S Kaye, John J Engemann, Henry S Fraimow, et al.
Archives of Internal Medicine|February 13, 2002
Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter speciesSara E Cosgrove, Keith S Kaye, George M Eliopoulous, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2025
Safety and Tolerability of Pivmecillinam During More Than Four Decades of Clinical Experience: A Systematic ReviewKeith S Kaye, Anne Santerre Henriksen, Morten Sommer, et al.
Infection Control and Hospital Epidemiology|December 11, 2023
Incidence and outcomes of hospital-associated respiratory virus infections by viral speciesJoshua G Petrie, Riley Moore, Adam S Lauring, et al.
Infection Control and Hospital Epidemiology|September 24, 2008
Complex surgical site infections and the devilish details of risk adjustment: important implications for public reportingDeverick J Anderson, Luke F Chen, Daniel J Sexton, et al.
Pageof 43